FRA
Front Row Advisors’s Takeda Pharmaceutical TAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33K | Sell |
86
-59
| -41% | -$912 | ﹤0.01% | 491 |
|
|
2025
Q1 | $2.16K | Hold |
145
| – | – | ﹤0.01% | 446 |
|
|
2024
Q4 | $1.92K | Hold |
145
| – | – | ﹤0.01% | 446 |
|
|
2024
Q3 | $2.06K | Sell |
145
-315
| -68% | -$4.48K | ﹤0.01% | 444 |
|
|
2024
Q2 | $5.95K | Hold |
460
| – | – | ﹤0.01% | 695 |
|
|
2024
Q1 | $6.39K | Buy |
460
+315
| +217% | +$4.38K | ﹤0.01% | 684 |
|
|
2023
Q4 | $2.07K | Sell |
145
-315
| -68% | -$4.5K | ﹤0.01% | 413 |
|
|
2023
Q3 | $7.12K | Hold |
460
| – | – | ﹤0.01% | 596 |
|
|
2023
Q2 | $7K | Hold |
460
| – | – | ﹤0.01% | 609 |
|
|
2023
Q1 | $8K | Buy |
460
+145
| +46% | +$2.52K | ﹤0.01% | 581 |
|
|
2022
Q4 | $5K | Sell |
315
-145
| -32% | -$2.3K | ﹤0.01% | 656 |
|
|
2022
Q3 | $6K | Hold |
460
| – | – | ﹤0.01% | 626 |
|
|
2022
Q2 | $6K | Hold |
460
| – | – | ﹤0.01% | 641 |
|
|
2022
Q1 | $7K | Hold |
460
| – | – | ﹤0.01% | 650 |
|
|
2021
Q4 | $6K | Hold |
460
| – | – | ﹤0.01% | 717 |
|
|
2021
Q3 | $8K | Hold |
460
| – | – | ﹤0.01% | 636 |
|
|
2021
Q2 | $8K | Sell |
460
-767
| -63% | -$13.3K | ﹤0.01% | 630 |
|
|
2021
Q1 | $22K | Hold |
1,227
| – | – | 0.01% | 388 |
|
|
2020
Q4 | $22K | Hold |
1,227
| – | – | 0.01% | 372 |
|
|
2020
Q3 | $22K | Sell |
1,227
-196
| -14% | -$3.51K | 0.01% | 368 |
|
|
2020
Q2 | $26K | Hold |
1,423
| – | – | 0.02% | 298 |
|
|
2020
Q1 | $26K | Buy |
1,423
+134
| +10% | +$2.45K | 0.02% | 295 |
|
|
2019
Q4 | $25K | Hold |
1,289
| – | – | 0.02% | 298 |
|
|
2019
Q3 | $22K | Sell |
1,289
-44
| -3% | -$751 | 0.02% | 305 |
|
|
2019
Q2 | $24K | Buy |
1,333
+255
| +24% | +$4.59K | 0.02% | 292 |
|
|
2019
Q1 | $22K | Buy |
+1,078
| New | +$22K | 0.02% | 303 |
|